Verve Therapeutics, Inc. 3 SEC Filings

Filed On	Filing
28 Jun 2024	Form 3: Politi Jason, Chief Technical Ops. Off. Holds 6,266 shares of Common Stock
28 Jun 2024	Form 3: Tatsis Ourania, Director No securities owned
28 Jun 2024	Form 3: Morrison Jodie Pope, Director No securities owned
25 Jun 2024	Form 3: Lister Troy, Chief Scientific Officer Holds 1,801 shares of Common Stock
05 Dec 2023	Form 3: Gv 2023 GP, L.l.c., Member of 10% Group and 3 others Holds 1,800,000 shares of Common Stock
19 Sep 2023	Form 3: Fiedorek Fred T., Chief Medical Officer No securities owned
23 Feb 2023	Form 3: Nickerson Joan, Chief Administrative Officer Holds 5,494 shares of Common Stock
09 Aug 2022	Form 3: Coats Lonnel, Director No securities owned
13 Jun 2022	Form 3: Cumbo Alexander, Director No securities owned
28 Dec 2021	Form 3: Fmr Llc, 10% owner Holds 1,037,294 shares of Common Stock
30 Nov 2021	Form 3: Dorval Allison, Chief Financial Officer No securities owned
16 Jun 2021	Form 3: Beam Therapeutics Inc., 10% owner Holds 276,075 shares of Common Stock
16 Jun 2021	Form 3: Redmile Group, Llc, 10% owner and 1 other
16 Jun 2021	Form 3: Biomatics Capital Partners, L.p., 10% owner
16 Jun 2021	Form 3: Joung Jae Keith, 10% owner Holds 307,219 shares of Common Stock
16 Jun 2021	Form 3: Kathiresan Sekar, Director Holds 404,036 shares of Common Stock
16 Jun 2021	Form 3: Yeshwant Krishna, Director
16 Jun 2021	Form 3: MacLean Michael F, Director No securities owned
16 Jun 2021	Form 3: Rozen Israel, 10% owner Holds 409,626 shares of Common Stock
16 Jun 2021	Form 3: Mikhail Sheila, Director

Comments